Total Payments
$4,846
2024 Payments
$130.99
Companies
29
Transactions
225
Medicare Patients
22,853
Medicare Billing
$2.8M
Payment Breakdown by Category
Food & Beverage$4,840 (99.9%)
Education$6.58 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,840 | 224 | 99.9% |
| Education | $6.58 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amarin Pharma Inc. | $802.85 | 40 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $738.63 | 35 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $528.38 | 24 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $437.92 | 20 | $0 (2021) |
| PFIZER INC. | $367.78 | 18 | $0 (2021) |
| Kowa Pharmaceuticals America, Inc. | $256.08 | 16 | $0 (2021) |
| Esperion Therapeutics, Inc. | $254.67 | 13 | $0 (2024) |
| iRhythm Technologies, Inc. | $220.71 | 9 | $0 (2024) |
| Boston Scientific Corporation | $139.29 | 4 | $0 (2019) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $123.42 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $130.99 | 6 | iRhythm Technologies, Inc. ($43.79) |
| 2023 | $427.87 | 15 | Novartis Pharmaceuticals Corporation ($91.97) |
| 2022 | $189.80 | 9 | Novartis Pharmaceuticals Corporation ($146.51) |
| 2021 | $997.94 | 50 | Janssen Pharmaceuticals, Inc ($155.85) |
| 2020 | $1,005 | 47 | Amarin Pharma Inc. ($245.91) |
| 2019 | $679.97 | 35 | Amarin Pharma Inc. ($149.41) |
| 2018 | $713.56 | 32 | Amarin Pharma Inc. ($112.59) |
| 2017 | $701.28 | 31 | Janssen Pharmaceuticals, Inc ($164.16) |
All Payment Transactions
225 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/26/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 07/15/2024 | iRhythm Technologies, Inc. | ZIO AT Patch (Device) | Food and Beverage | In-kind items and services | $25.33 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/18/2024 | Medtronic, Inc. | CLOSUREFAST (Device) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: EndoVenous Therapies | ||||||
| 03/25/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/23/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 01/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $33.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/10/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/19/2023 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $31.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/15/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/08/2023 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/25/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.75 | General |
| Category: DIABETES | ||||||
| 08/11/2023 | iRhythm Technologies, Inc. | ZIO XT Patch (Device) | Food and Beverage | In-kind items and services | $53.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/08/2023 | ShockWave Medical, Inc | SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) | Food and Beverage | In-kind items and services | $57.83 | General |
| Category: Lithoplasty | ||||||
| 08/04/2023 | Kiniksa Pharmaceuticals, Ltd. | Arcalyst (Drug) | Food and Beverage | Cash or cash equivalent | $34.69 | General |
| Category: Rheumatology | ||||||
| 07/21/2023 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/16/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 04/21/2023 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: Cardiovascular | ||||||
| 03/17/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/14/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/03/2023 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: Cardiovascular | ||||||
| 01/20/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $27.25 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/21/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/17/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: Cardiovascular | ||||||
| 12/16/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/09/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 2,072 | 4,052 | $1.7M | $519,763 |
| 2022 | 18 | 2,118 | 3,896 | $1.7M | $570,471 |
| 2021 | 55 | 8,976 | 16,592 | $1.6M | $853,769 |
| 2020 | 51 | 9,687 | 21,997 | $1.5M | $812,379 |
Total Patients
22,853
Total Services
46,537
Medicare Billing
$2.8M
Procedure Codes
147
All Medicare Procedures & Services
147 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2023 | 120 | 123 | $295,200 | $150,607 | 51.0% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 120 | 246 | $233,700 | $103,384 | 44.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 225 | 861 | $370,230 | $94,729 | 25.6% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 162 | 169 | $180,830 | $38,575 | 21.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 188 | 203 | $174,580 | $36,802 | 21.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 158 | 158 | $146,940 | $27,827 | 18.9% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 102 | 412 | $41,452 | $17,889 | 43.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 225 | 701 | $84,120 | $8,513 | 10.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 50 | 106 | $32,860 | $8,499 | 25.9% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 87 | 100 | $41,000 | $7,291 | 17.8% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 103 | 104 | $21,130 | $6,796 | 32.2% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 28 | 28 | $22,680 | $5,035 | 22.2% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 153 | 166 | $13,280 | $3,441 | 25.9% |
| 93979 | Ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 31 | 31 | $15,500 | $3,205 | 20.7% |
| J0280 | Injection, aminophyllin, up to 250 mg | Office | 2023 | 107 | 340 | $8,500 | $2,589 | 30.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $11,220 | $2,480 | 22.1% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 156 | 169 | $9,295 | $1,665 | 17.9% |
| J1245 | Injection, dipyridamole, per 10 mg | Office | 2023 | 23 | 95 | $3,325 | $278.47 | 8.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 17 | 23 | $920.00 | $157.52 | 17.1% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2022 | 104 | 214 | $203,300 | $144,598 | 71.1% |
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2022 | 104 | 107 | $256,800 | $132,246 | 51.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 230 | 829 | $356,470 | $97,316 | 27.3% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2022 | 158 | 167 | $178,690 | $40,900 | 22.9% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 184 | 201 | $172,860 | $39,168 | 22.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 182 | 188 | $174,840 | $34,860 | 19.9% |
About Dr. Gary Spektor, M.D
Dr. Gary Spektor, M.D is a Cardiovascular Disease healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043275092.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Spektor, M.D has received a total of $4,846 in payments from pharmaceutical and medical device companies, with $130.99 received in 2024. These payments were reported across 225 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($4,840).
As a Medicare-enrolled provider, Spektor has provided services to 22,853 Medicare beneficiaries, totaling 46,537 services with total Medicare billing of $2.8M. Data is available for 4 years (2020–2023), covering 147 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Brooklyn, NY
- Active Since 04/20/2006
- Last Updated 09/07/2019
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1043275092
Products in Payments
- Vascepa (Drug) $802.85
- ELIQUIS (Drug) $752.64
- ENTRESTO (Drug) $585.68
- XARELTO (Drug) $528.38
- Livalo (Drug) $256.08
- NEXLETOL (Drug) $254.67
- LEQVIO (Drug) $152.95
- LifeVest (Device) $123.42
- MULTAQ (Drug) $93.62
- ZIO Patch (Device) $92.29
- ZIO XT Patch (Device) $84.63
- Carnation Ambulatory Monitor (Device) $76.84
- BRILINTA (Drug) $71.96
- ROTABLATOR (Device) $65.91
- Impella (Device) $65.33
- Edarbi (Drug) $61.57
- SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) $57.83
- GlideWire (Device) $57.42
- CHANTIX (Drug) $53.06
- VERQUVO (Drug) $47.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Brooklyn
Dr. Felix Yang, M.d, M.D
Cardiovascular Disease — Payments: $599,451
Cardiovascular Disease $599,451
Ozgen Dogan, Md, MD
Cardiovascular Disease — Payments: $367,116
Cardiovascular Disease $367,116
Dr. Adam Budzikowski, M.d., Ph.d, M.D., PH.D
Cardiovascular Disease — Payments: $346,063
Cardiovascular Disease $346,063
Dr. Peter Rouvelas, M.d, M.D
Cardiovascular Disease — Payments: $339,378
Cardiovascular Disease $339,378
Dr. Ronald Wharton, M.d, M.D
Cardiovascular Disease — Payments: $298,083
Cardiovascular Disease $298,083
Dr. Sorin Brener, Md, MD
Cardiovascular Disease — Payments: $225,799
Cardiovascular Disease $225,799